ARCHIVES

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

This article is from The Cancer Letter archive.

Vol. 31 No. 16 | April 22, 2005

Download PDF Visit The Full Archive

Related Articles

Oral Combination Provides Alternative To IV Chemo For Multiple Myeloma

November 29, 2002

NCI Programs: Advisors Approve Plans For New Grants In Imaging Research

July 10, 1998

NCAB Okays Effort To Relax $5 Million Limit On Center Core Grants In Cancer Act Renewal

November 19, 1976

New Research Grant Awards

October 18, 1974

Recurrent Low-Grade Serous Carcinoma Less Responsive To Chemotherapy

March 28, 2008

Cost of Care: Medicare Patients Charged More In Outpatient Care Settings

November 1, 2013